The gastroenterologists, hepatologists, and colorectal surgeons at Columbia and Weill Cornell Medicine are renowned for their comprehensive clinical programs and innovative scientific research with expertise across the broad range of GI disorders. Our physicians use their highly specialized skills in advancing therapeutics and minimally invasive procedures to optimize quality of life for their patients.
Gastroenterology & GI Surgery
Featured Updates
Results from a new multi-center study, led by oncologists at NewYork-Presbyterian and Weill Cornell Medicine, has described for the first time a key biomarker – absolute lymphocyte count (ALC) – that has the potential to predict therapeutic response to chimeric antigen receptor (CAR) T-cell immunotherapy for patients with relapsed/refractory multiple myeloma. While this FDA-approved treatment is widely used, until now there has not been a way to predict whether B-cell maturation antigen (BCMA) CAR T-cell therapy would elicit a good response.
The Latest
Pediatric Neurology & Neurosurgery
Crossing Specialty Lines for Rare Genetic Neurocutaneous Conditions
